住血吸虫症用医薬品のアジア市場:メーカー別、種類別、用途別、市場予測(~2022)

◆英語タイトル:Asia-Pacific Drugs for Schistosomiasis Market by Manufacturers, Regions, Type and Application, Forecast to 2022
◆発行会社/調査会社:GlobalInfoResearch
◆商品コード:GIR705290994
◆発行日:2017年5月8日
◆調査対象地域:アジア
◆産業分野:ヘルスケア
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD4,480 ⇒換算¥492,800見積依頼/購入/質問フォーム
Corporate UserUSD8,960 ⇒換算¥985,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[住血吸虫症用医薬品のアジア市場:メーカー別、種類別、用途別、市場予測(~2022)]についてメールでお問い合わせはこちら
本調査レポートでは、住血吸虫症用医薬品のアジア市場について調査・分析し、住血吸虫症用医薬品のアジア市場概観、メーカー動向、メーカー別住血吸虫症用医薬品シェア、市場規模推移、市場規模予測、住血吸虫症用医薬品種類別分析、住血吸虫症用医薬品用途別分析データなどを含め、以下の構成でお届け致します。
・住血吸虫症用医薬品のアジア市場概観
・住血吸虫症用医薬品のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・住血吸虫症用医薬品のメーカー別販売動向、市場シェア、市場集中度、競争動向
・住血吸虫症用医薬品のアジア市場規模
・住血吸虫症用医薬品の種類別分析/市場規模推移
・住血吸虫症用医薬品の用途別分析/市場規模推移
・住血吸虫症用医薬品のアジア市場予測(種類別予測、用途別予測)
・住血吸虫症用医薬品の販売チャネル・代理店・貿易業者・ディーラー分析
...
*** レポート概要(サマリー)***

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Scope of the Report:
This report focuses on the Drugs for Schistosomiasis in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.

Market Segment by Manufacturers, this report covers
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Market Segment by Countries, covering
China
Japan
Korea
Taiwan
Southeast Asia
India
Australia

Market Segment by Type, covers
Praziquantel
Oxamniquine
Other

Market Segment by Applications, can be divided into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

There are 19 Chapters to deeply display the Asia-Pacific Drugs for Schistosomiasis market.

Chapter 1, to describe Drugs for Schistosomiasis Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Schistosomiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Drugs for Schistosomiasis, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application;

Chapter 14, Drugs for Schistosomiasis market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 17, to describe sales channel, distributors, traders, dealers etc.

Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source

*** レポート目次(コンテンツ)***

Table of Contents
1 Market Overview
1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
1.2.1 Praziquantel
1.2.2 Oxamniquine
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 S. haematobium
1.3.2 S. mansoni
1.3.3 S. japonicum
1.3.4 S. mekongi
1.3.5 S. intercalatum
1.4 Market Analysis by Countries
1.4.1 China Status and Prospect (2012-2022)
1.4.2 Korea Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 Taiwan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Australia Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shin Poong
2.1.1 Profile
2.1.2 Drugs for Schistosomiasis Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Shin Poong News
2.2 Merck
2.2.1 Profile
2.2.2 Drugs for Schistosomiasis Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Merck News
2.3 Bayer
2.3.1 Profile
2.3.2 Drugs for Schistosomiasis Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Bayer News
2.4 EIPICO
2.4.1 Profile
2.4.2 Drugs for Schistosomiasis Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 EIPICO News
2.5 Chandra Bhagat Pharma
2.5.1 Profile
2.5.2 Drugs for Schistosomiasis Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Chandra Bhagat Pharma News
2.6 Taj Pharmaceuticals
2.6.1 Profile
2.6.2 Drugs for Schistosomiasis Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Taj Pharmaceuticals News
3 Asia-Pacific Drugs for Schistosomiasis Market Competition, by Manufacturer
3.1 Asia-Pacific Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2016-2017)
3.2 Asia-Pacific Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2016-2017)
3.3 Asia-Pacific Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share
3.4.2 Top 5 Drugs for Schistosomiasis Manufacturer Market Share
3.5 Market Competition Trend
4 Asia-Pacific Drugs for Schistosomiasis Market Analysis by Countries/Regions
4.1 Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Countries/Regions
4.2 Asia-Pacific Drugs for Schistosomiasis Sales by Countries/Regions (2012-2017)
4.3 Asia-Pacific Drugs for Schistosomiasis Revenue (Value) by Countries (2012-2017)
5 Asia-Pacific Market Segmentation Drugs for Schistosomiasis by Type
5.1 Asia-Pacific Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 Asia-Pacific Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)
5.1.2 Asia-Pacific Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)
5.2 Praziquantel Sales Growth and Price
5.2.1 Asia-Pacific Praziquantel Sales Growth (2012-2017)
5.2.2 Asia-Pacific Praziquantel Price (2012-2017)
5.3 Oxamniquine Sales Growth and Price
5.3.1 Asia-Pacific Oxamniquine Sales Growth (2012-2017)
5.3.2 Asia-Pacific Oxamniquine Price (2012-2017)
5.4 Other Sales Growth and Price
5.4.1 Asia-Pacific Other Sales Growth (2012-2017)
5.4.2 Asia-Pacific Other Price (2012-2017)
6 Asia-Pacific Market Segmentation Drugs for Schistosomiasis by Application
6.1 Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
6.2 S. haematobium Sales Growth (2012-2017)
6.3 S. mansoni Sales Growth (2012-2017)
6.4 S. japonicum Sales Growth (2012-2017)
6.5 S. mekongi Sales Growth (2012-2017)
6.6 S. intercalatum Sales Growth (2012-2017)
7 China Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
7.1 China Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
7.2 China Drugs for Schistosomiasis Sales and Market Share by Type
7.3 China Drugs for Schistosomiasis Sales by Application (2012-2017)
7.4 China Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
7.4.1 China Drugs for Schistosomiasis Sales and Market Share by Manufacturer
7.4.2 China Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
7.5 China Drugs for Schistosomiasis Export and Import (2012-2017)
8 Japan Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
8.1 Japan Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
8.2 Japan Drugs for Schistosomiasis Sales and Market Share by Type
8.3 Japan Drugs for Schistosomiasis Sales by Application (2012-2017)
8.4 Japan Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
8.4.1 Japan Drugs for Schistosomiasis Sales and Market Share by Manufacturer
8.4.2 Japan Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
8.5 Japan Drugs for Schistosomiasis Export and Import (2012-2017)
9 Korea Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
9.1 Korea Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
9.2 Korea Drugs for Schistosomiasis Sales and Market Share by Type
9.3 Korea Drugs for Schistosomiasis Sales by Application (2012-2017)
9.4 Korea Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
9.4.1 Korea Drugs for Schistosomiasis Sales and Market Share by Manufacturer
9.4.2 Korea Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
9.5 Korea Drugs for Schistosomiasis Export and Import (2012-2017)
10 Taiwan Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
10.1 Taiwan Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
10.2 Taiwan Drugs for Schistosomiasis Sales and Market Share by Type
10.3 Taiwan Drugs for Schistosomiasis Sales by Application (2012-2017)
10.4 Taiwan Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
10.4.1 Taiwan Drugs for Schistosomiasis Sales and Market Share by Manufacturer
10.4.2 Taiwan Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
10.5 Taiwan Drugs for Schistosomiasis Export and Import (2012-2017)
11 Southeast Asia Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
11.1 Southeast Asia Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
11.2 Southeast Asia Drugs for Schistosomiasis Sales and Market Share by Type
11.3 Southeast Asia Drugs for Schistosomiasis Sales by Application (2012-2017)
11.4 Southeast Asia Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
11.4.1 Southeast Asia Drugs for Schistosomiasis Sales and Market Share by Manufacturer
11.4.2 Southeast Asia Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
11.5 Southeast Asia Drugs for Schistosomiasis Export and Import (2012-2017)
12 India Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
12.1 India Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
12.2 India Drugs for Schistosomiasis Sales and Market Share by Type
12.3 India Drugs for Schistosomiasis Sales by Application (2012-2017)
12.4 India Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
12.4.1 India Drugs for Schistosomiasis Sales and Market Share by Manufacturer
12.4.2 India Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
12.5 India Drugs for Schistosomiasis Export and Import (2012-2017)
13 Australia Drugs for Schistosomiasis Sales, Revenue, by Type, Application and Manufacturers
13.1 Australia Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
13.2 Australia Drugs for Schistosomiasis Sales and Market Share by Type
13.3 Australia Drugs for Schistosomiasis Sales by Application (2012-2017)
13.4 Australia Drugs for Schistosomiasis Sales, Revenue and Market Share by Manufacturer
13.4.1 Australia Drugs for Schistosomiasis Sales and Market Share by Manufacturer
13.4.2 Australia Drugs for Schistosomiasis Revenue and Market Share by Manufacturer
13.5 Australia Drugs for Schistosomiasis Export and Import (2012-2017)
14 Drugs for Schistosomiasis Market Forecast (2017-2022)
14.1 Asia-Pacific Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
14.2 Drugs for Schistosomiasis Market Forecast by Countries/Regions (2017-2022)
14.2.1 China Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
14.2.2 Japan Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
14.2.3 Korea Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
14.2.4 Taiwan Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
14.2.6 India Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
14.2.7 Australia Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
14.3 Drugs for Schistosomiasis Market Forecast by Type (2017-2022)
14.4 Drugs for Schistosomiasis Market Forecast by Application (2017-2022)
15 Drugs for Schistosomiasis Manufacturing Cost Analysis
15.1 Drugs for Schistosomiasis Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Drugs for Schistosomiasis Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Analyst Introduction
19.3 Data Source

List of Tables and Figures

Figure Drugs for Schistosomiasis Picture
Table Product Specifications of Drugs for Schistosomiasis
Figure Asia-Pacific Sales Market Share of Drugs for Schistosomiasis by Types in 2016
Table Types of Drugs for Schistosomiasis
Figure Praziquantel Picture
Table Major Manufacturers of Praziquantel
Figure Oxamniquine Picture
Table Major Manufacturers of Oxamniquine
Figure Other Picture
Table Major Manufacturers of Other
Table Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Applications in 2016
Table Applications of Drugs for Schistosomiasis
Figure S. haematobium Picture
Figure S. mansoni Picture
Figure S. japonicum Picture
Figure S. mekongi Picture
Figure S. intercalatum Picture
Figure China Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Korea Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Table Shin Poong Basic Information, Manufacturing Base and Competitors
Table Shin Poong Drugs for Schistosomiasis Type and Applications
Table Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Drugs for Schistosomiasis Type and Applications
Table Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Schistosomiasis Type and Applications
Table Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EIPICO Basic Information, Manufacturing Base and Competitors
Table EIPICO Drugs for Schistosomiasis Type and Applications
Table EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Type and Applications
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Type and Applications
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Asia-Pacific Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2015
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2015
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Asia-Pacific Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Sales by Countries/Regions (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Countries (2012-2017)
Figure Asia-Pacific 2012 Drugs for Schistosomiasis Sales Market Share by Countries
Figure Asia-Pacific 2016 Drugs for Schistosomiasis Sales Market Share by Countries
Figure Asia-Pacific Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Revenue by Countries (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Countries (2012-2017)
Table Asia-Pacific 2011 Drugs for Schistosomiasis Revenue Market Share by Countries
Table Asia-Pacific 2015 Drugs for Schistosomiasis Revenue Market Share by Countries
Table Asia-Pacific Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Revenue by Type (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Revenue Share by Type (2012-2017)
Figure Europe Praziquantel Sales Growth (2012-2017)
Figure Europe Praziquantel Price (2012-2017)
Figure Europe Oxamniquine Sales Growth (2012-2017)
Figure Europe Oxamniquine Price (2012-2017)
Figure Europe Other Sales Growth (2012-2017)
Figure Europe Other Price (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Asia-Pacific Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Figure Europe S. haematobium Sales Growth (2012-2017)
Figure Europe S. mansoni Sales Growth (2012-2017)
Figure Europe S. japonicum Sales Growth (2012-2017)
Figure Europe S. mekongi Sales Growth (2012-2017)
Figure Europe S. intercalatum Sales Growth (2012-2017)
Figure China Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure China Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table China Drugs for Schistosomiasis Sales by Type (2012-2017)
Table China Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table China Drugs for Schistosomiasis Sales by Application (2012-2017)
Table China Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table China Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure China Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure China Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table China Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure China Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure China Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table China Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Japan Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Japan Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Japan Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Japan Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Japan Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Japan Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table Japan Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Japan Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Japan Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Japan Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Japan Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure Japan Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table Japan Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Korea Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Korea Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Korea Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Korea Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Korea Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Korea Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table Korea Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Korea Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Korea Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Korea Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Korea Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure Korea Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table Korea Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Taiwan Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Taiwan Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Taiwan Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Taiwan Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Taiwan Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Taiwan Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table Taiwan Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Taiwan Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Taiwan Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Taiwan Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Taiwan Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure Taiwan Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table Taiwan Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Southeast Asia Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Southeast Asia Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Southeast Asia Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Southeast Asia Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Southeast Asia Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Southeast Asia Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table Southeast Asia Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Southeast Asia Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Southeast Asia Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Southeast Asia Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Southeast Asia Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure Southeast Asia Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table Southeast Asia Drugs for Schistosomiasis Export and Import (2012-2017)
Figure India Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure India Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table India Drugs for Schistosomiasis Sales by Type (2012-2017)
Table India Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table India Drugs for Schistosomiasis Sales by Application (2012-2017)
Table India Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table India Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure India Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure India Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table India Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure India Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure India Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table India Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Australia Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Australia Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Australia Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Australia Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Australia Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Australia Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Table Australia Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure Australia Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure Australia Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table Australia Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure Australia Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure Australia Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table Australia Drugs for Schistosomiasis Export and Import (2012-2017)
Figure Asia-Pacific Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
Table Asia-Pacific Drugs for Schistosomiasis Sales Forecast by Countries/Regions (2017-2022)
Table Asia-Pacific Drugs for Schistosomiasis Market Share Forecast by Countries/Regions (2017-2022)
Figure China Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Figure Japan Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Figure Korea Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Figure Taiwan Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Figure India Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Figure Australia Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)
Table Asia-Pacific Drugs for Schistosomiasis Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)
Table Asia-Pacific Drugs for Schistosomiasis Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure Drugs for Schistosomiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
Table Major Buyers of Drugs for Schistosomiasis
Table Distributors/Traders/ Dealers List


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR705290994 )"住血吸虫症用医薬品のアジア市場:メーカー別、種類別、用途別、市場予測(~2022)" (英文:Asia-Pacific Drugs for Schistosomiasis Market by Manufacturers, Regions, Type and Application, Forecast to 2022)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。